Study of an Evening Dose of Eszopiclone on Next Day Driving Ability & Psychomotor/Memory Function in Healthy Volunteers

NCT00368160 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia

Interventions

DRUG: Eszopiclone
DRUG: Placebo

Sponsor

Sumitomo Pharma America, Inc.